# US 2004/0082036 A1 · Modulation of hedgehog-mediated signaling pathway

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2004/0082036 A1
- Document ID: US20040082036A1
- Status: Published application
- Kind: A1
- Application number: 10/677,982
- Filed: 2003-10-01
- Published: 2004-04-29
- Earliest claimed: 1998-02-13
- Assignees: The Johns Hopkins University School of Medicine; Baylor College of Medicine
- Inventors: Philip A. Beachy; Ming-Jer Tsai; Sophia Tsai; Venkatesh Krishnan; Chien-Huan Chen
- Web page: https://patentgrep.com/patent/US20040082036A1

## CPC

- C07K 14/43577: {from flies}
- C07K 14/46: from vertebrates
- C07K 14/47: from mammals
- C07K 14/4702: {Regulators; Modulating activity}
- G01N 33/573: for enzymes or isoenzymes
- G01N 33/6872: {Intracellular protein regulatory factors and their receptors, e.g. including ion channels}
- G01N 2500/00: Screening for compounds of potential therapeutic value
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

The present invention provides transcription factors associated with the hedgehog signaling pathway that are regulated by dephosphorylation by phosphatases. Hedgehog response elements (HRE) that interact with the dephosphorylated transcription factors are also provided as well as methods for identifying compounds that are phosphatase inhibitors. Methods of treating tumors in a subject by modulating the phosphorylation of the transcription factor are also included.

## Claims

### Claim 1

An isolated transcription factor involved in a hedgehog-mediated signaling pathway, said transcription factor comprising at least one phosphorylation site, wherein said transcription factor is dephosphorylated in response to said hedgehog mediated signaling pathway, and said transcription factor binds to a hedgehog response element.

### Claim 2 (depends on 1)

The transcription factor of claim 1, wherein said hedgehog response element is a sonic hedgehog response element (ShhRE).

### Claim 3 (depends on 2)

The transcription factor of claim 2, wherein said sonic hedgehog response element comprises a nucleic acid sequence comprising 5′GTTCTACATAATGCGCCG-3′ (SEQ ID NO:1).

### Claim 4

A method for modulating expression of a target gene, said method comprising modulating the phosphorylation of a transcription factor that interacts with a hedgehog response element, wherein said hedgehog response element is operatively associated with said target gene.

### Claim 5 (depends on 4)

The method of claim 4, wherein said target gene is involved in a hedgehog signaling pathway.

### Claim 6 (depends on 4)

The method of claim 4, wherein said phosphorylation of said transcription factor is modulated by affecting the activity of a phosphatase.

### Claim 7 (depends on 4)

The method of claim 4, wherein said modulation is inhibition.

### Claim 8 (depends on 4)

The method of claim 4, wherein said modulation is stimulation.

### Claim 9 (depends on 6)

The method of claim 6, wherein said phosphatase is expressed from a vector, said vector comprising a nucleic acid sequence which encodes said phosphatase.

### Claim 10 (depends on 6)

The method of claim 6, wherein said phosphatase is a PP2A phosphatase.

### Claim 11 (depends on 6)

The method of claim 6, wherein said phosphatase is inhibited by a PP2A phosphatase inhibitor.

### Claim 12 (depends on 11)

The method of claim 11, wherein said phosphatase inhibitor is okadaic acid.

### Claim 13 (depends on 11)

The method of claim 11, wherein said phosphatase inhibitor is calyculin A.

### Claim 14 (depends on 4)

The method of claim 4, wherein said hedgehog signaling pathway is selected from the group consisting of Drosophila, Zebrafish, Xenopus, chicken, murine and human hedgehog signaling pathways.

### Claim 15 (depends on 4)

The method of claim 4, wherein said hedgehog signaling pathway is human hedgehog signaling pathway.

### Claim 16 (depends on 4)

The method of claim 4, wherein said transcription factor is a Ci/Gli transcription factor family member.

### Claim 17 (depends on 16)

The method of claim 16, wherein said transcription factor is Ci.

### Claim 18 (depends on 16)

The method of claim 16, wherein said transcription factor is a Gli family member.

### Claim 19 (depends on 4)

The method of claim 4, wherein said response element is a Ci-response element.

### Claim 20 (depends on 4)

The method of claim 4, wherein said response element is a Gli-response element.

### Claim 21 (depends on 4)

The method of claim 4, wherein said response element is a sonic hedgehog response element.

### Claim 22 (depends on 21)

The method of claim 21, wherein said sonic hedgehog response element comprises a nucleic acid sequence comprising 5′-GTTCTACATAATGCGCCG-3′ (SEQ ID NO:1).

### Claim 23 (depends on 21)

The method of claim 21, wherein said transcription factor interacts with said sonic hedgehog response element.

### Claim 24 (depends on 4)

The method of claim 4, wherein said target gene is the ptc gene.

### Claim 25 (depends on 4)

The method of claim 4, wherein said target gene is a gene encoding COUP-TFII.

### Claim 26

A method for modulating proliferation or differentiation of neuronal cells comprising modulating the phosphorylation of a transcription factor that interacts with a hedgehog response element operatively associated with a target gene, said target gene encoding a polypeptide that modulates proliferation or differentiation of neuronal cells.

### Claim 27 (depends on 26)

The method of claim 26, wherein said target gene encodes COUP-TFII.

### Claim 28 (depends on 26)

The method of claim 26, further comprising detecting the proliferation or differentiation of said neuronal cells.

### Claim 29 (depends on 28)

The method of claim 28, wherein said detecting comprises assaying for the presence of a neuronal marker.

### Claim 30 (depends on 29)

The method of claim 29, wherein said neuronal marker is selected from the group consisting of Isl1, HNF3β and SC-1.

### Claim 31

A method for treating a cell proliferative disorder in a subject, said method comprising modulating the phosphorylation of a transcription factor that interacts with a hedgehog response element by administering to the subject a modulating effective amount of a phosphatase inhibitor.

### Claim 32 (depends on 31)

The method of claim 31, wherein said response element is operatively associated with a target gene.

### Claim 33 (depends on 32)

The method of claim 32, wherein said target gene is the ptc gene.

### Claim 34 (depends on 31)

The method of claim 31, wherein the cell proliferative disorder is selected from the group consisting of basal cell carcinoma, medulloblastoma and meningioma.

### Claim 35

A method for inhibiting bone defects in a subject, said method comprising modulating the phosphorylation of a transcription factor that interacts with a hedgehog response element operatively associated with a target gene, said target gene encoding a polypeptide involved in mediating bone development.

### Claim 36

A method for diagnosing a hedgehog signaling pathway-mediated familial midline defect in a subject comprising determining the level of phosphorylated transcription factor as compared to the level of dephosphorylated transcription factor, wherein said transcription factor interacts with a hedgehog response element in response to said hedgehog signaling pathway; and correlating said level of phosphorylated transcription factor as compared to said level of dephosphorylated transcription factor with the susceptibility for a familial midline defect.

### Claim 37 (depends on 36)

The method of claim 36, wherein said familial midline defect is selected from the group consisting of cyclopia and neural tube defect.

### Claim 38

A method for identifying a compound that inhibits a phosphatase involved in a hedgehog signaling pathway comprising:
a) incubating components comprising the compound, a transcription factor that binds to a hedgehog response element operatively associated with a target gene, and a phosphatase, under conditions sufficient to allow the components to interact; and
b) measuring the ability of the compound to affect the hedgehog signaling pathway by detecting an increase or decrease in expression of the target gene.

### Claim 39 (depends on 38)

The method of claim 38, wherein the hedgehog signaling pathway is the sonic hedgehog signaling pathway.

### Claim 40 (depends on 38)

The method of claim 38, wherein the target gene is chloramphenicol acetyl transferase (CAT).

### Claim 41 (depends on 38)

The method of claim 38, wherein the target gene is a lacZ gene.

### Claim 42 (depends on 38)

The method of claim 38, wherein the response element is ShhRE.

### Claim 43 (depends on 38)

The method of claim 38, wherein detection of expression is by detection of protein product.

### Claim 44 (depends on 38)

The method of claim 38, wherein detection of expression is by detection of mRNA.

### Claim 45 (depends on 38)

The method of claim 38, wherein the target gene further includes a reporter means is selected from the group consisting of a radioisotope, a fluorescent compound, a bioluminescent compound, a chemiluminescent compound, a metal chelator, or an enzyme.

### Claim 46

A method for identifying a compound which affects a hedgehog signaling pathway comprising:
a) incubating components comprising the compound, a phosphorylated transcription factor that binds to a hedgehog response element and a phosphatase, under conditions sufficient to allow the components to interact; and
b) measuring the ability of the compound to affect hedgehog signaling pathway by detecting the phosphorylation state of the transcription factor in the presence and absence of the compound.
